Abstract

ObjectiveTo assess the impact of serum luteinizing hormone (LH) levels on the day of initiation of controlled ovarian stimulation (COS) after pituitary suppression on early pregnancy loss and assisted reproductive technology (ART) outcomes.DesignRetrospective cohort study.SettingUniversity-affiliated hospital.PatientsA total of 9540 normogonadotrophic patients were treated with a GnRH agonist for in vitro fertilization (IVF). Based on the serum concentration of LH on the COS initiation day, patients were divided into low (<1 mIU/mL, n=2838), medium (1–1.49 mIU/mL, n=3357), or high (≥1.5 mIU/mL, n=3345) LH groups and received either fresh embryo transfer (ET) or frozen ET (women with high ovarian response, insufficient endometrial thickness, or requesting frozen ET). A total of 6279 cycles were fresh ET (1960, 2222, and 2097 in the low, medium, and high LH groups, respectively).Intervention(s)During IVF/ICSI, a GnRH agonist was used to suppress pituitary function in the midluteal phase or follicular phase, and then gonadotropin was used to induce COS.Main Outcome Measure(s)The early pregnancy loss rate (ePLR) and live-birth rate (LBR) for fresh ET, as well as the cumulative ePLR and LBR for the entire ovarian stimulation cycle, were compared.ResultsIn the fresh ET cycles, the high, medium and low LH groups had an ePLR of 8.6%, 11.9% and 12.5%, respectively, and LBR of 42.1%, 37.9% and 37.5%, respectively. There were no significant differences in terms of clinical pregnancy rate (CPR), late pregnancy loss rate (lPLR), and ectopic pregnancy rate (EPR) among the three LH groups. For the entire ovarian stimulation cycle, the high LH group had a greater number of retrieved oocytes compared with the low and medium LH groups. Among the groups of high, medium and low LH, the cumulative CPR were 72.8%, 69.8% and 68.8%, respectively, and the cumulative LBR were 63.4%, 60.4% and 58.5%, respectively. There were no significant differences in the cumulative ePLR, lPLR, or EPR. After multivariable logistic regression, compared with the high LH group, the adjusted odds ratio of early pregnancy loss in the low and medium LH group were 1.429 (1.065-1.919, P = 0.018) and 1.389 (1.041-1.853, P = 0.026).ConclusionsAfter pituitary suppression by a GnRH-agonist during IVF, a low LH level (<1.5 mIU/mL) on the COS initiation day was associated with adverse ART outcomes—including fewer oocytes, higher ePLR and lower LBR in fresh ET—and lower cumulative CPR and LBR in the entire ovarian-stimulation cycle. And LH on the COS initiation day was an independent factor affecting ePLR after multivariate regression.

Highlights

  • The development of in vitro fertilization-embryo transfer (IVFET) and other assisted reproductive technologies (ART) has advanced our understanding of the role of gonadotropins in human reproductive function [1, 2]

  • The results indicated that luteinizing hormone (LH) on the day of COS initiation was significantly associated with early pregnancy loss in women of non-advanced age (< 35 years of age), BMI < 25, no history of miscarriage and artificial abortion, history of gravidity, normal ovarian reserve (AFC >5, number of retrieved oocytes >3), and those who experienced the transfer of at least one high-quality embryo or of two embryos

  • The results of 9540 GnRH-agonist cycles and 6279 fresh ET cycles implied that low LH concentration (

Read more

Summary

Introduction

The development of in vitro fertilization-embryo transfer (IVFET) and other assisted reproductive technologies (ART) has advanced our understanding of the role of gonadotropins in human reproductive function [1, 2]. During a natural menstrual cycle, luteinizing hormone (LH) plays a key role in promoting oocyte maturation and triggering the ovulatory process in the late follicular phase [3, 4]. At the stage of follicular development, LH can interact with the LH/chorionic gonadotrophin receptors (LHCGRs) on theca cells to promote the production of androgen. The androgen disseminates into the surrounding granulosa cells and is eventually aromatized to estrogen to promote follicular development [5]. In previous work, during the early follicular phase, functional LHCGRs were detected in human endometrium despite serum LH being at a low level, suggesting that LH might be involved in facilitating reproductive processes in the endometrium [6]. It is reasonable to speculate that LH in early follicular development may be related to the outcome of ART treatment

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call